| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Breast cancer susceptibility—A new look at an old model
|
Peto, Julian
|
|
2002
|
1 |
5 |
p. 411-412
2 p.
|
article
|
| 2 |
Critical role for Gab2 in transformation by BCR/ABL
|
Sattler, Martin
|
|
2002
|
1 |
5 |
p. 479-492
14 p.
|
article
|
| 3 |
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
|
Kelly, Louise M
|
|
2002
|
1 |
5 |
p. 421-432
12 p.
|
article
|
| 4 |
EGF receptor activation by heterologous mechanisms
|
Carraway III, Kermit L
|
|
2002
|
1 |
5 |
p. 405-406
2 p.
|
article
|
| 5 |
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
|
Liu, David
|
|
2002
|
1 |
5 |
p. 445-457
13 p.
|
article
|
| 6 |
Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia
|
Sawyers, Charles L
|
|
2002
|
1 |
5 |
p. 413-415
3 p.
|
article
|
| 7 |
Focus on acute leukemias
|
Gilliland, D.Gary
|
|
2002
|
1 |
5 |
p. 417-420
4 p.
|
article
|
| 8 |
HIF activation identifies early lesions in VHL kidneys
|
Mandriota, Stefano J
|
|
2002
|
1 |
5 |
p. 459-468
10 p.
|
article
|
| 9 |
HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions
|
Heinen, Christopher D.
|
|
2002
|
1 |
5 |
p. 469-478
10 p.
|
article
|
| 10 |
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
|
Weisberg, Ellen
|
|
2002
|
1 |
5 |
p. 433-443
11 p.
|
article
|
| 11 |
Myc—Is this the oncogene from Hell?
|
Soucek, Laura
|
|
2002
|
1 |
5 |
p. 406-408
3 p.
|
article
|
| 12 |
p53 stabilization is decreased upon NFκB activation
|
Tergaonkar, Vinay
|
|
2002
|
1 |
5 |
p. 493-503
11 p.
|
article
|
| 13 |
Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment
|
McLaughlin, Margaret E
|
|
2002
|
1 |
5 |
p. 408-410
3 p.
|
article
|
Journal description